Literature DB >> 11838565

Postasphyxial encephalopathy in preterm neonates.

K Sridhar1, P Kumar, S Katariya, A Narang.   

Abstract

OBJECTIVE: Perinatal asphyxia is an important determinant of infant neurological outcome. There are very few studies looking exclusively at postasphyxial encephalopathy in preterm neonates.
METHODS: We studied the neurologic and sonographic abnormalities in 40 preterm babies with severe birth asphyxia during their hospital stay and till 3 months corrected age. RESULT: 87.5 % of the asphyxiated preterm babies had neonatal neurologic abnormality, compared to only 17% of the control babies (p<0.0001). Generalised hypotonia and reduced activity were the commonest abnormalities (observed in 85% of asphyxiated babies) while depressed sensorium (60%) and seizures (35%) were seen in more severe cases. White matter disease (WMD-including periventricular flare, cerebral edema and periventricular leucomalacia) was significantly more frequent in the study cases (34.5% in study cases vs 7.5% in controls, p<0.0001) as was grade 3/4 intraventricular hemorrhage(IVH) (25% in study cases vs 2.5% in controls, p<0.0001). There was 11 fold higher mortality among the asphyxiated babies (23 deaths in study cases vs 2 in controls, p<0.0001).
CONCLUSION: The survivors had a significantly higher incidence of both mild and severe neurological abnormalities at corrected age of 3 months among the asphyxiated babies. There was a good correlation between the severity of the neonatal encephalopathy as well as the sonographic findings and the outcome.

Entities:  

Mesh:

Year:  2001        PMID: 11838565     DOI: 10.1007/bf02722925

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  15 in total

1.  An optimality score for the neurologic examination of the term newborn.

Authors:  L Dubowitz; E Mercuri; V Dubowitz
Journal:  J Pediatr       Date:  1998-09       Impact factor: 4.406

2.  Neurological aspects of perinatal asphyxia.

Authors:  J K Brown; R J Purvis; J O Forfar; F Cockburn
Journal:  Dev Med Child Neurol       Date:  1974-10       Impact factor: 5.449

3.  Mortality and morbidity after intrapartum asphyxia in the preterm fetus.

Authors:  J A Low; R S Galbraith; D W Muir; H L Killen; E A Pater; E J Karchmar
Journal:  Obstet Gynecol       Date:  1992-07       Impact factor: 7.661

4.  Developmental sequence of periventricular leukomalacia. Correlation of ultrasound, clinical, and nuclear magnetic resonance functions.

Authors:  L M Dubowitz; G M Bydder; J Mushin
Journal:  Arch Dis Child       Date:  1985-04       Impact factor: 3.791

5.  Hypoxic-ischemic encephalopathy in term neonates: perinatal factors and outcome.

Authors:  N N Finer; C M Robertson; R T Richards; L E Pinnell; K L Peters
Journal:  J Pediatr       Date:  1981-01       Impact factor: 4.406

6.  Neonatal encephalopathy following fetal distress. A clinical and electroencephalographic study.

Authors:  H B Sarnat; M S Sarnat
Journal:  Arch Neurol       Date:  1976-10

7.  New Ballard Score, expanded to include extremely premature infants.

Authors:  J L Ballard; J C Khoury; K Wedig; L Wang; B L Eilers-Walsman; R Lipp
Journal:  J Pediatr       Date:  1991-09       Impact factor: 4.406

8.  A review of the Amiel-Tison neurologic evaluation of the newborn and infant.

Authors:  A P McCarraher-Wetzel; R C Wetzel
Journal:  Am J Occup Ther       Date:  1984-09

9.  Post-asphyxial encephalopathy in a preterm infant.

Authors:  S Niijima; M I Levene
Journal:  Dev Med Child Neurol       Date:  1989-06       Impact factor: 5.449

10.  Intrapartum asphyxia in the preterm fetus less than 2000 gm.

Authors:  J A Low; S L Wood; H L Killen; E A Pater; E J Karchmar
Journal:  Am J Obstet Gynecol       Date:  1990-02       Impact factor: 8.661

View more
  1 in total

1.  Maternal dexamethasone and EEG hyperactivity in preterm fetal sheep.

Authors:  Joanne O Davidson; Josine S L T Quaedackers; Sherly A George; Alistair Jan Gunn; Laura Bennet
Journal:  J Physiol       Date:  2011-06-06       Impact factor: 5.182

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.